Guided Therapeutics, Inc. (GTHP)

Market Cap	20.97M
Revenue (ttm)	1,000.00
Net Income (ttm)	-2.61M
Shares Out	78.97M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,060
Average Volume	15,493
Open	0.2000
Previous Close	0.2300
Day's Range	0.1900 - 0.2660
52-Week Range	0.0644 - 0.3000
Beta	0.12
RSI	68.55
Earnings Date	Aug 14, 2025

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorpo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Financial Performance

In 2024, Guided Therapeutics's revenue was $7,000, a decrease of -92.86% compared to the previous year's $98,000. Losses were -$2.59 million, -31.07% less than in 2023.